£100
1 period on recordActiveSC812293Private limited companyStirling
JELLAGEN PHARMA LIMITED
Significant control: Jellagen Limited (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Jellagen Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Jellagen Pharma Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
JELLAGEN PHARMA LIMITED is an active private limited company (company number SC812293) incorporated on 31 May 2024, registered in Stirling. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 December 2024, showing net assets of £100, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public.
Peer position · net assets
By net assets it sits in the lower half of 278 comparable companies in Other (median £129, upper quartile £59k).
02
Ownership and control
- Jellagen Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 31 May 20242 yrs ago
- Next accounts due
- 30 September 202626 days overdue
- Confirmation statement due
- 14 June 2027in 231 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
0
1 period on record| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | £100 | — | — | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £100 at 31 December 2024
- Incorporated two to five years agoIncorporated 31 May 2024
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 231 days
- Next accounts due26 days overdue
- Accounts period endNet assets £100 · micro accounts
- Incorporated
08
Similar companies in the UK
- VENOMITE LTDChipping Campden · inc. Jun 2024
- BIOCAMAT CONSULTS LIMITEDCrewe · inc. Jun 2024
- CCR CONSULTING LIMITEDLeominster · inc. Jun 2024
- MY SINE LTDMildenhall · inc. Jun 2024
- ULTRAPLEX BIOANALYSIS LTDSandbach · inc. May 2024
- HANANO TECHNOLOGIES LTDCheltenham · inc. Jun 2024
All companies incorporated on 31 May 2024 · in May 2024.
09
Reminders for JELLAGEN PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.